1st Quarter - Report

PARRY, ROMANI, DECONCINI & SYMMS for INTL ACADEMY OF COMPOUNDING PHARMACISTS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No legislation introduced yet.

LobbyistCovered position, as disclosed
DENNIS DECONCINI —
JAMES ROCK —
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No legislation introduced yet.

LobbyistCovered position, as disclosed
DENNIS DECONCINI —
JAMES ROCK —
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to compounding pharmacies. No legislation introduced yet.

LobbyistCovered position, as disclosed
DENNIS DECONCINI —
JAMES ROCK —
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.